We have focused on the involvement of IGF2BP1 in lung adenocarcinoma (LUAD), where we have observed that IGF2BP1 synergizes with mutant Kras to accelerate tumor progression [4]. The gene discussed is IGF2BP1; the disease is lung adenocarcinoma.